| Typicality: | 0.527 |
| Saliency: | 0.397 |
| from the fda | 10 | other |
| in the time frame under study | 6 | temporal |
| in 2009 | 5 | temporal |
| drug → receive → accelerated approval | 20 |
| drug → be granted → accelerated approval | 16 |
| drug → be given → accelerated approval | 11 |
| drug → get → accelerated approval | 5 |
| drug → received → accelerated approval | 4 |
| drug → accelerate → approval | 3 |
| negative | neutral | positive |
| 0.133 | 0.518 | 0.349 |
| Raw frequency | 59 |
| Normalized frequency | 0.397 |
| Modifier score | 0.833 |
| Perplexity | 453.212 |